In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

How Patients Are Transforming Pharma R&D

Executive Summary

Patient-centric R&D is imperative for pharma in delivering effective medicines and better outcomes. The push to implement it is challenging long-held biopharma business practices, including how clinical trials are designed, recruited and run – and what they measure.


Related Content

The New World Of Pharma – Markets, Messaging And The Flash Mob
Pharma's Progress In Precision Medicine
Alzheimer's Disease: Defusing The Bomb By 2025
Investor Interest In Wearable Medical Technology Grows
PatientsLikeMe Pioneers Social Medicine
IMI Offers €12m For Patient Engagement Project
Digital Health Is Changing Health Care. Is it Changing Pharma?


Related Companies